Taro Penalties Exceed $400m As It Admits Fixing Prices With Sandoz

Criminal Penalty And Civil Damages Announced

 
• By Dean Rudge

In the latest development arising from ongoing generic pricing investigations in the US, Taro has admitted to fixing prices, allocating customers and rigging bids for generic medicines, under a conspiracy with multiple firms, including Sandoz.

Department of Justice
Taro has agreed to cooperate fully with the DoJ Antitrust Division’s ongoing criminal investigation • Source: Shutterstock

More from Deals

More from Business